Phosphoproteomic analysis of kinase-deficient mice reveals multiple TAK1 targets in osteoclast differentiation

Biochemical and Biophysical Research Communications

Volumn 463, Issue 4, 2015, Pages 1284-1290

  Sumiya, Eriko ^a,b,c   Negishi Koga, Takako ^a,c   Nagai, Yusuke ^a,c   Suematsu, Ayako ^a,c   Suda, Tomomi ^a,c   Shinohara, Masahiro ^b,c   Sato, Kojiro ^b,f   Sanjo, Hideki ^d,g   Akira, Shizuo ^d,e   Takayanagi, Hiroshi ^a,b,c  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d OSAKA UNIVERSITY   (Japan)

^e OSAKA UNIVERSITY   (Japan)

^f SAITAMA MEDICAL UNIVERSITY   (Japan)

^g SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Osteoclast; Osteopetrosis; Phosphoproteome; RANKL; TAK1

Indexed keywords

CALCINEURIN; COLONY STIMULATING FACTOR 1; GUANOSINE TRIPHOSPHATASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOCLAST DIFFERENTIATION FACTOR; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; MAP KINASE KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; PHOSPHOPROTEIN; PROTEOME;

ALBERS SCHOENBERG DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; BONE MASS; CELL DIFFERENTIATION; CONTROLLED STUDY; CORTICAL THICKNESS (BONE); ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEFICIENCY; GENE LOSS; GENE ONTOLOGY; GENOTYPE; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; LOXP SITE; MALE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PHENOTYPE; PHOSPHOPROTEOMIC ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEOMICS; SIGNAL TRANSDUCTION; SURVIVAL RATE; TRABECULAR BONE; AMINO ACID SEQUENCE; ANIMAL; C57BL MOUSE; CHEMISTRY; CYTOLOGY; METABOLISM; MOLECULAR GENETICS;

MUS;

AMINO ACID SEQUENCE; ANIMALS; CELL DIFFERENTIATION; MAP KINASE KINASE KINASES; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; NF-KAPPA B; OSTEOCLASTS; PHOSPHOPROTEINS; PROTEOME;

EID: 84940460160     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.06.105     Document Type: Article

References (34)

1. T. Nakashima, M. Hayashi, and H. Takayanagi New insights into osteoclastogenic signaling mechanisms Trends Endocrinol. Metab. 23 2012 582 590
2. S.R. Mihaly, J. Ninomiya-Tsuji, and S. Morioka TAK1 control of cell death Cell Death Differ. 21 2014 1667 1676
3. A.A. Ajibade, H.Y. Wang, and R.F. Wang Cell type-specific function of TAK1 in innate immune signaling Trends Immunol. 34 2013 307 316
4. L. Dai, C. Aye Thu, X.Y. Liu, J. Xi, and P.C. Cheung TAK1, more than just innate immunity IUBMB Life 64 2012 825 834
5. H. Sakurai Targeting of TAK1 in inflammatory disorders and cancer Trends Pharmacol. Sci. 33 2012 522 530
6. J. Mizukami, G. Takaesu, H. Akatsuka, and et al. Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6 Mol. Cell. Biol. 22 2002 992 1000
7. M.B. Greenblatt, J.H. Shim, W. Zou, and et al. The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice J. Clin. Investig. 120 2010 2457 2473
8. B. Lamothe, W.K. Webster, A. Gopinathan, and et al. TRAF6 ubiquitin ligase is essential for RANKL signaling and osteoclast differentiation Biochem. Biophys. Res. Commun. 359 2007 1044 1049
9. M.C. Walsh, G.K. Kim, P.L. Maurizio, and et al. TRAF6 autoubiquitination-independent activation of the NFkappaB and MAPK pathways in response to IL-1 and RANKL PLoS One 3 2008 e4064
10. A. Besse, B. Lamothe, A.D. Campos, and et al. TAK1-dependent signaling requires functional interaction with TAB2/TAB3 J. Biol. Chem. 282 2007 3918 3928
11. H. Huang, J. Ryu, J. Ha, and et al. Osteoclast differentiation requires TAK1 and MKK6 for NFATc1 induction and NF-kappaB transactivation by RANKL Cell. Death Differ. 13 2006 1879 1891
12. S. Sato, H. Sanjo, K. Takeda, and et al. Essential function for the kinase TAK1 in innate and adaptive immune responses Nat. Immunol. 6 2005 1087 1095
13. B. Qi, Q. Cong, P. Li, and et al. Ablation of Tak1 in osteoclast progenitor leads to defects in skeletal growth and bone remodeling in mice Sci. Rep. 4 2014 7158
14. G. Swarnkar, K. Karuppaiah, G. Mbalaviele, and et al. Osteopetrosis in TAK1-deficient mice owing to defective NF-kappaB and NOTCH signaling Proc. Natl. Acad. Sci. U. S. A. 112 2015 154 159
15. B. Lamothe, Y. Lai, M. Xie, and et al. TAK1 is essential for osteoclast differentiation and is an important modulator of cell death by apoptosis and necroptosis Mol. Cell. Biol. 33 2013 582 595
16. T. Nakamura, Y. Imai, T. Matsumoto, and et al. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts Cell 130 2007 811 823
17. K. Tsuji-Takechi, T. Negishi-Koga, E. Sumiya, and et al. Stage-specific functions of leukemia/lymphoma-related factor (LRF) in the transcriptional control of osteoclast development Proc. Natl. Acad. Sci. U. S. A. 109 2012 2561 2566
18. N.A. Sims, and T.J. Martin Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit Bonekey Rep. 3 2014 481
19. M. Ashburner, C.A. Ball, J.A. Blake, and et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium Nat. Genet. 25 2000 25 29
20. D.W. Huang, B.T. Sherman, and R.A. Lempicki Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources Nat. Protoc. 4 2009 44 57
21. Y. Xue, J. Ren, X. Gao, and et al. GPS 2.0, a tool to predict kinase-specific phosphorylation sites in hierarchy Mol. Cell. Proteomics 7 2008 1598 1608
22. S. Yang, and Y.P. Li RGS10-null mutation impairs osteoclast differentiation resulting from the loss of [Ca2+]i oscillation regulation Genes Dev. 21 2007 1803 1816
23. N. Zini, S. Avnet, S. Ghisu, and et al. Effects of prelamin A processing inhibitors on the differentiation and activity of human osteoclasts J. Cell. Biochem. 105 2008 34 40
24. W. Li, L.S. Yeo, C. Vidal, and et al. Decreased bone formation and osteopenia in lamin a/c-deficient mice PLoS One 6 2011 e19313
25. M.H. Sheng, and K.H. Lau Role of protein-tyrosine phosphatases in regulation of osteoclastic activity Cell. Mol. Life Sci. 66 2009 1946 1961
26. L. Van Wesenbeeck, P.R. Odgren, F.P. Coxon, and et al. Involvement of PLEKHM1 in osteoclastic vesicular transport and osteopetrosis in incisors absent rats and humans J. Clin. Invest 117 2007 919 930
27. M. Shinohara, T. Koga, K. Okamoto, and et al. Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals Cell 132 2008 794 806
28. M.M. Weivoda, and M.J. Oursler The Roles of Small GTPases in Osteoclast Biology Orthop. Muscular Syst. 3 2014
29. P. Goulimari, H. Knieling, U. Engel, and R. Grosse LARG and mDia1 link Galpha12/13 to cell polarity and microtubule dynamics Mol. Biol. Cell. 19 2008 30 40
30. J.M. Swiercz, R. Kuner, J. Behrens, and S. Offermanns Plexin-B1 directly interacts with PDZ-RhoGEF/LARG to regulate RhoA and growth cone morphology Neuron 35 2002 51 63
31. J. Zangari, M. Partisani, F. Bertucci, and et al. EFA6B antagonizes breast cancer Cancer Res. 74 2014 5493 5506
32. B.J. de Kreuk, A. Schaefer, E.C. Anthony, and et al. The human minor histocompatibility antigen 1 is a RhoGAP PLoS One 8 2013 e73962
33. L. Lanzetti, A. Palamidessi, L. Areces, and et al. Rab5 is a signalling GTPase involved in actin remodelling by receptor tyrosine kinases Nature 429 2004 309 314
34. H. Stenmark, G. Vitale, O. Ullrich, and M. Zerial Rabaptin-5 is a direct effector of the small GTPase Rab5 in endocytic membrane fusion Cell 83 1995 423 432